Myopathy News and Research

RSS
The myopathies are neuromuscular disorders in which the primary symptom is muscle weakness due to dysfunction of muscle fiber. Other symptoms of myopathy can include include muscle cramps, stiffness, and spasm. Myopathies can be inherited (such as the muscular dystrophies) or acquired (such as common muscle cramps).
Ultragenyx reports results from UX001 Phase 1 study on HIBM

Ultragenyx reports results from UX001 Phase 1 study on HIBM

EMA grants orphan designations to Ultragenyx UX001, UX003 for treatment of HIBM and MPS 7

EMA grants orphan designations to Ultragenyx UX001, UX003 for treatment of HIBM and MPS 7

Ultragenyx completes UX001 Phase 1 study on hereditary inclusion body myopathy

Ultragenyx completes UX001 Phase 1 study on hereditary inclusion body myopathy

Patients worried about statin use after label warnings from FDA

Patients worried about statin use after label warnings from FDA

FDA grants orphan drug designation to Ultragenyx UX003 for treatment of MPS 7

FDA grants orphan drug designation to Ultragenyx UX003 for treatment of MPS 7

Websites advertising statins for sale contain poor levels of safety information

Websites advertising statins for sale contain poor levels of safety information

ACTF, Merck announce new HIV initiatives

ACTF, Merck announce new HIV initiatives

Researchers discover more about function of muscle stem cells

Researchers discover more about function of muscle stem cells

Researchers to begin drug development projects for rare and neglected diseases

Researchers to begin drug development projects for rare and neglected diseases

Health supplement hope for child muscle disease

Health supplement hope for child muscle disease

FDA EMDAC votes to recommend approval of Merck's VYTORIN for pre-dialysis CKD

FDA EMDAC votes to recommend approval of Merck's VYTORIN for pre-dialysis CKD

Merck announces results from ISENTRESS Phase III combination study on HIV-1

Merck announces results from ISENTRESS Phase III combination study on HIV-1

AANEM Foundation strengthens and expands research initiatives

AANEM Foundation strengthens and expands research initiatives

Merck receives FDA approval for JUVISYNC to treat type 2 diabetes

Merck receives FDA approval for JUVISYNC to treat type 2 diabetes

Oral steroid users twice as likely to have severe vitamin D deficiency

Oral steroid users twice as likely to have severe vitamin D deficiency

New treatment strategy for dominant forms of muscular dystrophy

New treatment strategy for dominant forms of muscular dystrophy

Colchicine more effective than placebo for recurrent pericarditis

Colchicine more effective than placebo for recurrent pericarditis

ISENTRESS demonstrates comparable efficacy to efavirenz in treatment-naïve adult HIV-1 patients

ISENTRESS demonstrates comparable efficacy to efavirenz in treatment-naïve adult HIV-1 patients

Positive results from etanercept pilot study against dermatomyositis

Positive results from etanercept pilot study against dermatomyositis

Merck announces changes to high-dose simvastatin prescribing information in the U.S.

Merck announces changes to high-dose simvastatin prescribing information in the U.S.